DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The Changing View of High-Grade Serous Ovarian Cancer

(2012) E. M. J. J. Berns et al.   CANCER RESEARCH

Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome

(2012) Z. C. Wang et al.   CLINICAL CANCER RESEARCH

Hereditary ovarian cancer: Beyond the usual suspects

(2012) Kathryn P. Pennington et al.   GYNECOLOGIC ONCOLOGY

Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer

(2012) Kelly L. Bolton   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group

(2012) Kathryn Alsop et al.   JOURNAL OF CLINICAL ONCOLOGY

Genome Sequencing Identifies a Basis for Everolimus Sensitivity

(2012) G. Iyer et al.   SCIENCE

A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients

(2011) M. A. Didraga et al.   BREAST CANCER RESEARCH AND TREATMENT

FOXQ1 Regulates Epithelial-Mesenchymal Transition in Human Cancers

(2011) Y. Qiao et al.   CANCER RESEARCH

Human BRCA1-Associated Breast Cancer: No Increase in Numerical Chromosomal Instability Compared to Sporadic Tumors

(2011) T. Focken et al.   CYTOGENETIC AND GENOME RESEARCH

Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma

(2011) Robert A Soslow et al.   MODERN PATHOLOGY

Integrated genomic analyses of ovarian carcinoma

(2011) D. Bell et al.   NATURE

The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory

(2010) Robert J. Kurman et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Calculator for ovarian carcinoma subtype prediction

(2010) Steve E Kalloger et al.   MODERN PATHOLOGY

Genetic profiles distinguish different types of hereditary ovarian cancer

(2010) Domanska   ONCOLOGY REPORTS

MicroRNA Let-7a Inhibits Proliferation of Human Prostate Cancer Cells In Vitro and In Vivo by Targeting E2F2 and CCND2

(2010) Qingchuan Dong et al.   PLoS One

Subtypes of familial breast tumours revealed by expression and copy number profiling

(2009) Nic Waddell et al.   BREAST CANCER RESEARCH AND TREATMENT

Recurrent copy number alterations inBRCA1-mutated ovarian tumors alter biological pathways

(2009) Karin Leunen et al.   HUMAN MUTATION

A Limited Panel of Immunomarkers Can Reliably Distinguish Between Clear Cell and High-grade Serous Carcinoma of the Ovary

(2008) Martin Köbel et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH

(2008) Simon A. Joosse et al.   BREAST CANCER RESEARCH AND TREATMENT

Genetic heterogeneity by comparative genomic hybridization in BRCAx breast cancers

(2008) Anita Mangia et al.   CANCER GENETICS AND CYTOGENETICS

The Average Cumulative Risks of Breast and Ovarian Cancer for Carriers of Mutations in BRCA1 and BRCA2 Attending Genetic Counseling Units in Spain

(2008) R. L. Milne et al.   CLINICAL CANCER RESEARCH

Genome-Wide Loss of Heterozygosity and Uniparental Disomy in BRCA1/2-Associated Ovarian Carcinomas

(2008) C. S. Walsh et al.   CLINICAL CANCER RESEARCH

Across array comparative genomic hybridization: A strategy to reduce reference channel hybridizations

(2008) Tineke E. Buffart et al.   GENES CHROMOSOMES & CANCER

Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma

(2008) C. Blake Gilks et al.   HUMAN PATHOLOGY